Health Tech SPAC Execs Ink $10M Investor Settlement

By Emilie Ruscoe · January 21, 2026, 10:18 PM EST

Former executives of a health technology company that went public via merger with a blank check company have reached a $10 million deal to settle claims they wiped out investors with...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Kenneth S. Grossman v. David Sin et al

Case Number

Court

California Central

Nature of Suit

Securities/Commodities

Date Filed

November 09, 2023

Recent Articles By Emilie

November 10, 2025
IRhythm Denied Early Win On Investor Scienter & Loss Claims
November 04, 2025
IRhythm Investors Seek Class Cert. In Heart Device Suit
November 03, 2025
Biotech Co. Agrees To Reforms After Co-Founder's Conviction
October 28, 2025
Ex-Philips CEO Can't Undo Finding He Misled Shareholders
October 27, 2025
Moderna Says Vax Efficacy Math Doesn't Show Investor Fraud
October 17, 2025
Sana Biotech Fights Investor Fraud Claims Over Trial Data
October 09, 2025
Tivity Health Investors Seek Final OK Of $17M Settlement
October 06, 2025
2 Firms To Lead Humana Investor Suit Over Post-COVID Costs
September 16, 2025
BrainStorm Can't Shed Investors' ALS Treatment Trial Claims
September 11, 2025
Dental Supply Co.'s $84M Price-Fixing Deal Gets Final OK